LGND - LIGAND PHARMACEUTICALS INC

208.95
4.710   2.254%

Share volume: 189,218
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%
$204.24
4.71
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-08-2024 08-07-2024 11-08-2024 02-28-2025 05-09-2025 08-08-2025 11-07-2025
Total revenue 30.978 M 41.531 M 51.812 M 42.812 M 45.333 M 47.627 M 115.461 M
Cost of revenue 0.000 0.000 2.449 M 8.625 M 4.849 M 2.907 M 3.801 M
Gross profit 30.978 M 41.531 M 49.363 M 34.187 M 40.484 M 44.720 M 111.660 M
    34.07% 18.86% -30.74% 18.42% 10.46% 149.69%  
Operating expenses 16.922 M 22.977 M 30.150 M 30.030 M 68.886 M 26.742 M 49.465 M
Selling general and admin 10.951 M 17.623 M 24.475 M 25.605 M 18.801 M 20.175 M 28.446 M
Research and development 5.971 M 5.354 M 5.675 M 4.425 M 50.085 M 6.567 M 21.019 M
Total expenses 27.990 M 60.631 M 46.220 M 43.824 M 76.700 M 36.276 M 56.729 M
    116.62% -23.77% -5.18% 75.02% -52.70% 56.38%  
Operating income 2.988 M -19.100 M 3.143 M -9.637 M -36.216 M 8.444 M 54.931 M
Ebit 796.000 K -52.623 M -9.352 M -16.345 M -38.717 M 9.816 M 130.375 M
Pretax income 113.447 M -65.390 M -6.339 M -39.200 M -50.180 M 11.223 M 141.137 M
    -157.64% -90.31% 518.39% 28.01% -122.37% 1,157.57%  
Income tax 27.308 M -13.479 M 833.000 K -8.112 M -7.729 M 6.376 M 23.864 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income 86.139 M -51.911 M -7.172 M -31.088 M -42.451 M 4.847 M 117.273 M
    -160.26% 86.18% -333.46% -36.55% 111.42% 2,319.50%